Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate COVID-19 Adult Patients Treated with Ovydso (Olgotrelvir), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19

7M ago

PremiumPress Releases

Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients

8M ago

PremiumPress Releases

Sorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse Bid

9M ago

PremiumPress Releases

Sorrento Announces Launch of Voluntary Offering to Dividend Short Holders with Deadline to Participate by July 27, 2023

9M ago

SCLX

$Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study$

PremiumPress Releases

Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study

10M ago

PremiumPress Releases

Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19

10M ago

PremiumPress Releases

Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness

10M ago

More SRNE News >

0L85 News on the Web

2023-09-22

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

Yahoo Finance

Neutral

2023-09-16

Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy

TalkMarkets

Neutral

2023-08-08

Sorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse Bid

Yahoo Finance

Neutral

2023-07-27

Sorrento Issues a “FAQ” in Response to Large Number Of Urgent Requests from Scilex Dividend Short Holders and/or Record Holders

Yahoo Finance

Bearish

2023-06-15

Sorrento Therapeutics, Inc.'s Bankruptcy Court Issues Temporary Restraining Order Against Brokerage Firms and Suspends Short-Sales of Dividended Scilex Stock

Yahoo Finance

Neutral

2023-06-13

Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness

Yahoo Finance

Bullish

2023-05-25

3 Penny Stocks to Make You the Millionaire Next Door

InvestorPlace

Neutral

2023-05-23

Affimed N.V. (AFMD) Reports Q1 Loss, Lags Revenue Estimates

Zacks

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

Not enough data to generate Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0L85’s Media Buzz Sentiment?

Currently, no data Available

What is GB:0L85’s weekly average amount of articles?

Currently, no data Available

What is GB:0L85’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

CGEMCullinan Management

MRNSMarinus

EWEdwards Lifesciences

ELVElevance Health

ABTAbbott Labs

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing